Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Companion Diagnostics Sub-Section of Anatomic Pathology Department in a Mid-Sized General Hospital: Start Up and Maintenance].

Rinsho byori. The Japanese journal of clinical pathology - 1 Jul 2015

Nakayama Hirofumi, Yasuhara Mayumi

Abstract excerpt

We introduce the establishment of a companion diagnostics sub-section of an anatomic pathology department in our mid-sized general hospital. Recent cancer pharmacotherapy targets are growth factor receptors and their associated signal transduction molecules. The presence or absence of mutations in these genes influences the effects of drugs on an individual tumor. Gene polymorphisms of anti-cancer drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to EGFR gene
Share to KRAS gene
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Mutation

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 26591440

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Companion Diagnostics Sub-Section of Anatomic Pathology Department in a Mid-Sized General Hospital: Start Up and Maintenance].PMID 26591440Read ↗

[Genetic analysis in oncology--contra].Semantic proximity Read ↗

[Tailored therapy in gastrointestinal and hepatic cancer--toward ideal medicine through genomic science].Semantic proximity Read ↗

INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASS.Semantic proximity Read ↗

[New Classification for Advanced Colorectal Cancer Using CancerPlex®Genomic Tests].Semantic proximity Read ↗

Clinical Significance of Multi-Cancer Genome Profiling: Data from A Japan HospitalSemantic proximity Read ↗

Technological advances in clinical individualized medication for cancer therapy: from genes to whole organismSemantic proximity Read ↗

[Molecular profiling in daily practice for cholangiocarcinoma].Semantic proximity Read ↗

[From ASCO and WCLC 2005 to the clinical practice: targeted therapies].Semantic proximity Read ↗

The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific SocietiesSemantic proximity Read ↗

Companion diagnostic testing for targeted cancer therapies: an overview.Semantic proximity Read ↗

[Current update and testing procedures for genetic diagnosis in malignant neoplasm: additional information on pathological tests].Semantic proximity Read ↗

[A New Era of Colorectal Cancer Treatment Being Led by a Precise Analysis of Somatic Mutational Profiles Including RAS, BRAF Mutation and Microsatellite Instability Status].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.